Table 7 Comparison of systemic symptom reported during menstruation within-group
Systemic symptom | Time | Auriculotherapy group (n = 41) n (%) | Mefenamic acid group (n = 42) n (%) | Systemic symptom | Time | Auriculotherapy group (n = 41) n (%) | Mefenamic acid group (n = 42) n (%) |
|---|---|---|---|---|---|---|---|
Nausea | Control cycle | 22 (53.7) | 15 (35.7) | Fatigue | Control cycle | 36 (87.8) | 37 (88.1) |
1st cycle | 14 (34.1) | 16 (38.1) | 1st cycle | 32 (78) | 32 (76.2) | ||
2nd cycle | 8 (19.5) | 13 (31) | 2nd cycle | 27 (65.9) | 30 (71.4) | ||
aP value | 0.002 | 0.58 | aP value | 0.02 | 0.02 | ||
Vomiting | Control cycle | 4 (9.8) | 6 (14.3) | Diarrhea | Control cycle | 18 (43.9) | 12 (28.6) |
1st cycle | 3 (7.3) | 3 (7.1) | 1st cycle | 8 (19.5) | 8 (19) | ||
2nd cycle | 1 (2.4) | 2 (4.8) | 2nd cycle | 7 (17.1) | 6 (14.3) | ||
aP value | 0.31 | 0.11 | aP value | 0.001 | 0.045 | ||
Headache | Control cycle | 16 (39) | 18 (42.9) | Nervousness | Control cycle | 28 (68.3) | 27 (64.3) |
1st cycle | 17 (41.5) | 17 (40.5) | 1st cycle | 19 (46.3) | 23 (54.8) | ||
2nd cycle | 8 (19.5) | 19 (45.2) | 2nd cycle | 13 (31.7) | 21 (50) | ||
aP value | 0.02 | 0.65 | aP value | < 0.001 | 0.13 |